Announcements Trials
Browse Landscape

Phase

Phase 3 27Phase 2 23Phase NA 5Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pathologic Complete Response 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 254Cyclophosphamide 244Specimen Handling 196fludarabine 173Magnetic Resonance Spectroscopy 170Biopsy 145Nivolumab 124Carboplatin 99Radiotherapy 92Paclitaxel 90venetoclax 81Cisplatin 80fludarabine phosphate 79Gemcitabine 78Injections 69Ipilimumab 66Dexamethasone 63atezolizumab 58Cetuximab 57Bevacizumab 57Azacitidine 57Radiation 56Fluorouracil 56durvalumab 54Radiosurgery 51Temozolomide 48Oxaliplatin 44Rituximab 43Irinotecan 43Docetaxel 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Observation × 1 year × Clear all
NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡